Success Metrics

Clinical Success Rate
96.1%

Based on 98 completed trials

Completion Rate
96%(98/102)
Active Trials
0(0%)
Results Posted
4%(4 trials)
Terminated
4(4%)

Phase Distribution

Ph phase_4
12
11%
Ph phase_2
40
35%
Ph not_applicable
24
21%
Ph phase_1
15
13%
Ph phase_3
22
19%

Phase Distribution

15

Early Stage

40

Mid Stage

34

Late Stage

Phase Distribution113 total trials
Phase 1Safety & dosage
15(13.3%)
Phase 2Efficacy & side effects
40(35.4%)
Phase 3Large-scale testing
22(19.5%)
Phase 4Post-market surveillance
12(10.6%)
N/ANon-phased studies
24(21.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.1%

98 of 103 finished

Non-Completion Rate

4.9%

5 ended early

Currently Active

0

trials recruiting

Total Trials

113

all time

Status Distribution
Completed(98)
Terminated(5)
Other(10)

Detailed Status

Completed98
unknown8
Terminated4
Suspended2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
113
Active
0
Success Rate
96.1%
Most Advanced
Phase 4

Trials by Phase

Phase 115 (13.3%)
Phase 240 (35.4%)
Phase 322 (19.5%)
Phase 412 (10.6%)
N/A24 (21.2%)

Trials by Status

completed9887%
withdrawn11%
suspended22%
unknown87%
terminated44%

Recent Activity

Clinical Trials (113)

Showing 20 of 113 trialsScroll for more
NCT00074581Phase 3

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Completed
NCT00000872Phase 2

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Completed
NCT00001091Phase 1

Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

Completed
NCT00000841Phase 3

A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

Completed
NCT00000831Phase 2

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

Completed
NCT00000789Phase 2

A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection

Completed
NCT00000838Phase 2

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Completed
NCT00001083Phase 2

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Completed
NCT00001063Phase 2

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

Completed
NCT00001084Phase 2

A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Completed
NCT00001095Phase 2

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Completed
NCT00000891Phase 2

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Completed
NCT00000851Phase 2

Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children

Completed
NCT00312091Phase 1

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children

Completed
NCT00001067Phase 2

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

Completed
NCT00007202Phase 2

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Completed
NCT00006144Phase 2

A Study of HIV-Disease Development in Aging

Completed
NCT00001087Phase 2

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Completed
NCT00050895Phase 3

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Completed
NCT00036452Phase 2

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Completed

Drug Details

Intervention Type
DRUG
Total Trials
113